+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Zeffix"

From
Zeffix - API Insight, 2022 - Product Thumbnail Image

Zeffix - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Zeffix- Drug Insight, 2019 - Product Thumbnail Image

Zeffix- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Zeffix is a market for drugs used to treat liver and kidney disorders. It includes drugs used to treat a variety of conditions, including hepatitis, cirrhosis, and kidney failure. These drugs are used to reduce inflammation, improve liver and kidney function, and reduce the risk of complications. Zeffix drugs are typically prescribed by a doctor and are available in both generic and brand-name forms. The Zeffix market is highly competitive, with many companies offering a variety of drugs to treat liver and kidney disorders. Some of the major players in the market include AbbVie, Gilead Sciences, Merck, Pfizer, and Novartis. These companies offer a range of drugs, including antivirals, immunosuppressants, and antifibrotics. Other companies in the market include Bristol-Myers Squibb, AstraZeneca, and Sanofi. Show Less Read more